FGFR2 gene amplification and clinicopathological features in gastric cancer

BACKGROUND: Frequency of FGFR2 amplification, its clinicopathological features, and the results of high-throughput screening assays in a large cohort of gastric clinical samples remain largely unclear. METHODS: Drug sensitivity to a fibroblast growth factor receptor (FGFR) inhibitor was evaluated in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matsumoto, K, Arao, T, Hamaguchi, T, Shimada, Y, Kato, K, Oda, I, Taniguchi, H, Koizumi, F, Yanagihara, K, Sasaki, H, Nishio, K, Yamada, Y
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2012
Materias:
Molecular Diagnostics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3322955/
https://ncbi.nlm.nih.gov/pubmed/22240789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.603
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares